PLANET LABS PBC (PL)

US72703X1063 - Common Stock

2.16  0 (0%)

After market: 2.19 +0.03 (+1.39%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PL. PL was compared to 80 industry peers in the Professional Services industry. No worries on liquidiy or solvency for PL as it has an excellent financial health rating, but there are worries on the profitability. PL is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

In the past year PL has reported negative net income.
In the past year PL has reported a negative cash flow from operations.

1.2 Ratios

Looking at the Return On Assets, with a value of -20.78%, PL is doing worse than 86.25% of the companies in the same industry.
PL has a worse Return On Equity (-27.79%) than 82.50% of its industry peers.
Industry RankSector Rank
ROA -20.78%
ROE -27.79%
ROIC N/A
ROA(3y)-23.35%
ROA(5y)N/A
ROE(3y)-55.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PL's Gross Margin of 50.99% is fine compared to the rest of the industry. PL outperforms 65.00% of its industry peers.
The Profit Margin and Operating Margin are not available for PL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PL has more shares outstanding
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -0.08, we must say that PL is in the distress zone and has some risk of bankruptcy.
PL has a worse Altman-Z score (-0.08) than 85.00% of its industry peers.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACC8.97%

2.3 Liquidity

PL has a Current Ratio of 2.96. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
PL has a Current ratio of 2.96. This is amongst the best in the industry. PL outperforms 88.75% of its industry peers.
PL has a Quick Ratio of 2.96. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
PL's Quick ratio of 2.96 is amongst the best of the industry. PL outperforms 88.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.96

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.58% over the past year.
Looking at the last year, PL shows a very strong growth in Revenue. The Revenue has grown by 22.45%.
The Revenue has been growing by 25.97% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)46.58%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q66.67%
Revenue 1Y (TTM)22.45%
Revenue growth 3Y25.97%
Revenue growth 5YN/A
Revenue growth Q2Q11.43%

3.2 Future

PL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.89% yearly.
Based on estimates for the next years, PL will show a very strong growth in Revenue. The Revenue will grow by 20.11% on average per year.
EPS Next Y56.39%
EPS Next 2Y28.65%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue Next Year15.37%
Revenue Next 2Y16.71%
Revenue Next 3Y20.11%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PL's earnings are expected to grow with 23.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.65%
EPS Next 3Y23.89%

0

5. Dividend

5.1 Amount

PL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PLANET LABS PBC

NYSE:PL (2/23/2024, 7:05:55 PM)

After market: 2.19 +0.03 (+1.39%)

2.16

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap621.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.78%
ROE -27.79%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 50.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.96
Quick Ratio 2.96
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)46.58%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y56.39%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)22.45%
Revenue growth 3Y25.97%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y